Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
R Salani, FJ Backes, MFK Fung… - American journal of …, 2011 - Elsevier
Although gynecologic cancers account for only 10% of all new cancer cases in women,
these cancers account for 20% of all female cancer survivors. Improvements in cancer care
have resulted in almost 10 million cancer survivors, and this number is expected to grow.
Therefore, determining the most cost-effective clinical surveillance for detection of
recurrence is critical. Unfortunately, there has been a paucity of research in what are the
most cost-effective strategies for surveillance once patients have achieved a complete …
these cancers account for 20% of all female cancer survivors. Improvements in cancer care
have resulted in almost 10 million cancer survivors, and this number is expected to grow.
Therefore, determining the most cost-effective clinical surveillance for detection of
recurrence is critical. Unfortunately, there has been a paucity of research in what are the
most cost-effective strategies for surveillance once patients have achieved a complete …